Drug factory · FDA FEI 3017440477

AqVida GmbH

Werkstr. 21, Dassow, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, Dec 5, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2022: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
NelarabineMakes it Shorla Oncology Inc. 81927-111, 81927-375

FDA inspection history

EndedResultProgramProblems noted
Dec 5, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 8, 2022Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.